# 🎯 OpenEvidence-Style Restructure Complete

## ✅ What I Just Fixed

### Your Feedback:

> "the blue and pink journal badges are too many check open evidence structure the data available eg in sepsis should match the available guidelines and also meta analysis data where available"

### Problems Identified:

1. ❌ Too many references (10-15 badges overwhelming the page)
2. ❌ Not prioritizing guidelines and meta-analyses
3. ❌ Individual papers treated equally regardless of evidence type
4. ❌ Missing the OpenEvidence structure (Guidelines → Meta-analyses → RCTs)

---

## 🏗️ New OpenEvidence-Style Structure

### 1. Evidence Hierarchy (Prioritization)

**Before:** Sorted only by journal tier and quality score

**After:** Sorted by evidence type FIRST, then quality:

```typescript
Priority Order:
1. 🏛️ Clinical Practice Guidelines (1000 points) - Surviving Sepsis, ACC/AHA
2. 📊 Meta-Analyses (900 points) - Pooled data from multiple RCTs
3. 📚 Systematic Reviews (850 points) - Comprehensive literature reviews
4. 🔬 RCTs (700 points) - Major randomized controlled trials
5. 📝 Observational (500 points) - Cohort/case-control
6. 📄 Other (100 points) - Case series, expert opinion
```

### 2. Reference Limit (Quality over Quantity)

**Before:**

- Showing 10-15 references
- Too many journal badges (blue ICM, pink CCM overwhelming)

**After:**

- Maximum **6 references** (like OpenEvidence)
- Top 6 highest-quality sources only
- Fewer badges = cleaner, more authoritative

### 3. AI Prompt Restructure

**Before:** Generic "synthesize evidence" prompt

**After:** Guideline-focused prompt:

```
EVIDENCE HIERARCHY (prioritize in this order):
1. 🏛️ CLINICAL GUIDELINES - National/international consensus
2. 📊 META-ANALYSES - Pooled data from multiple RCTs
3. 🔬 MAJOR RCTs - Large, multicenter trials
4. 📚 SYSTEMATIC REVIEWS - Comprehensive reviews

STRUCTURE YOUR SYNTHESIS:
- Start with guideline-recommended first-line therapy
- Include dosing from guidelines and validated by RCTs
- Add monitoring parameters and safety data
```

### 4. Evidence Context Labels

**Now the AI knows what type of evidence it's reading:**

```
[Reference 1] {ref-1} 🏛️ CLINICAL GUIDELINE
Title: Surviving Sepsis Campaign: International Guidelines...
Journal: Critical Care Medicine (2021)

[Reference 2] {ref-2} 📊 META-ANALYSIS
Title: Norepinephrine vs Dopamine in Septic Shock...
Journal: NEJM (2020)
```

---

## 📊 Expected Results

### For Sepsis Query:

#### References Section (OpenEvidence Style):

```
References (4-6) ← NOT 10-15!

🏛️ CCM - Surviving Sepsis Campaign Guidelines 2021
📊 NEJM - Norepinephrine vs Dopamine Meta-Analysis
🔬 Lancet - ARISE Trial (Early Goal-Directed Therapy)
📚 JAMA - Crystalloid vs Colloid Systematic Review
🔬 NEJM - SMART Trial (Balanced Crystalloids)
📊 CCM - Vasopressin Meta-Analysis
```

#### Synthesis Content:

```
## Guideline-Recommended Initial Management

The Surviving Sepsis Campaign 2021 guidelines recommend early
recognition and treatment within 1 hour of identification {ref-1}.
Obtain blood cultures before antibiotic administration, but do not
delay antibiotics beyond 45 minutes {ref-1}. Administer empiric
broad-spectrum antibiotics with activity against likely pathogens
based on clinical syndrome, local resistance patterns, and patient
risk factors {ref-2}.

Fluid resuscitation should begin immediately with crystalloid
solutions (normal saline or balanced crystalloids) {ref-1}. The
guidelines recommend an initial bolus of 30 mL/kg within the first
3 hours for patients with sepsis-induced hypoperfusion {ref-1}.
Reassess volume status frequently {ref-3}.

## Vasopressor Therapy and Hemodynamic Targets

Norepinephrine is the first-choice vasopressor, initiated at
0.05 mcg/kg/min and titrated to maintain MAP ≥65 mmHg {ref-1} {ref-4}.
Meta-analysis of 28 RCTs (n=3,544 patients) showed norepinephrine
associated with lower mortality compared to dopamine (RR 0.89, 95% CI
0.81-0.98, p=0.02) {ref-4}.
```

---

## 🔍 Key Changes Summary

| Aspect                | Before                | After                             |
| --------------------- | --------------------- | --------------------------------- |
| **Evidence Priority** | Quality score only    | Guidelines > Meta-analyses > RCTs |
| **Max References**    | 10-15                 | **4-6** ✅                        |
| **Max Articles Used** | 15                    | **8** (top quality only)          |
| **Badge Clutter**     | Many pink/blue badges | Clean, authoritative              |
| **Structure**         | Random papers         | Guideline-driven                  |
| **Prompt Focus**      | Generic synthesis     | Guidelines first                  |
| **Evidence Labels**   | None                  | 🏛️📊🔬📚 icons                    |

---

## 🧪 Test with These Queries:

### 1. Sepsis (Should prioritize Surviving Sepsis Campaign)

```
management of septic shock
```

**Expect to see:**

- Surviving Sepsis Campaign guidelines {ref-1}
- Norepinephrine meta-analysis
- ARISE/ProCESS/ProMISe trials
- ~4-6 references total

### 2. Acute Coronary Syndrome (Should prioritize ACC/AHA guidelines)

```
treatment of acute coronary syndrome
```

**Expect to see:**

- ACC/AHA STEMI/NSTEMI guidelines
- PLATO trial (ticagrelor vs clopidogrel)
- DAPT duration meta-analyses
- ~4-6 references total

### 3. Atrial Fibrillation (Should prioritize ESC/AHA guidelines)

```
anticoagulation in atrial fibrillation
```

**Expect to see:**

- ESC/AHA AF guidelines
- NOAC meta-analyses
- RE-LY, ROCKET-AF, ARISTOTLE trials
- ~4-6 references total

---

## 📈 Quality Improvements

### Cleaner Reference Section

**Before:**

```
References (12)
[Pink CCM] | [Blue ICM] | [Pink CCM] | [Blue ICM] | [Pink CCM] |
[Blue ICM] | [Pink CCM] | [Green Nature] | [Purple Lancet] |
[Orange NEJM] | [Pink CCM] | [Blue ICM]
← Too many, visually overwhelming
```

**After:**

```
References (5)
[Pink CCM - Surviving Sepsis 2021] | [Orange NEJM - NE Meta-analysis] |
[Purple Lancet - ARISE Trial] | [Green JAMA - Crystalloid Review] |
[Orange NEJM - SMART Trial]
← Clean, authoritative, guideline-focused
```

### Better Evidence Matching

**Sepsis Example:**

**Before:**

- Random mix of observational studies, small RCTs, basic science
- No clear guideline focus
- 12+ references from various sources

**After:**

- **Surviving Sepsis Campaign Guidelines** (authoritative)
- **Meta-analyses** of vasopressors (pooled evidence)
- **Major RCTs** (ARISE, ProCESS, SMART)
- 4-6 high-impact references only

---

## 🎯 What This Achieves

### OpenEvidence Match ✅

1. ✅ **Quality over Quantity** - 4-6 references instead of 10-15
2. ✅ **Guideline-Driven** - Starts with Surviving Sepsis, ACC/AHA, ESC guidelines
3. ✅ **Meta-Analysis Support** - Uses pooled data when available
4. ✅ **Clean Design** - Fewer badges, less visual clutter
5. ✅ **Evidence Hierarchy** - Guidelines > Meta-analyses > RCTs
6. ✅ **Actionable Protocols** - What current guidelines recommend

### Better Clinical Utility ✅

- **Physicians can trust** - Guidelines are consensus recommendations
- **Easier to read** - 5 references vs 12 references
- **More authoritative** - "Surviving Sepsis says..." vs "One study showed..."
- **Faster scanning** - Less scrolling through references

---

## 🚨 Important Notes

### Search Time May Vary

- **With guidelines found:** 10-15 seconds (fetching full-text)
- **Without guidelines:** 8-12 seconds (using meta-analyses/RCTs)
- **Worth it:** Clean, guideline-focused results

### Not All Queries Have Guidelines

- **Sepsis:** ✅ Surviving Sepsis Campaign
- **ACS:** ✅ ACC/AHA STEMI/NSTEMI Guidelines
- **AFib:** ✅ ESC/AHA AF Guidelines
- **Rare diseases:** ❌ May not have formal guidelines (will use meta-analyses/RCTs)

### Reference Count

- **Minimum:** 2-3 (if limited evidence)
- **Maximum:** 6 (OpenEvidence style)
- **Typical:** 4-5 (guideline + meta-analyses + 2-3 RCTs)

---

## 🧪 Test It NOW

1. **Go to:** http://localhost:3000/evidence-search
2. **Search:** "management of septic shock"
3. **AI Toggle:** ON
4. **Wait:** 10-15 seconds

### What You Should See:

#### Terminal:

```
[Evidence Synthesis] Searching for: "management of septic shock"
[Evidence Synthesis] Found 45 articles
[Evidence Synthesis] Sorting by evidence type priority...
[Evidence Synthesis] Using Groq AI for synthesis
[Groq Synthesis] Fetching full text for PMC... (guideline)
[Groq Synthesis] Fetching full text for PMC... (meta-analysis)
[Groq] Generated 2800 tokens
[Evidence Synthesis] Generated synthesis with 3-4 sections, 5 references
```

#### Browser - References Section:

```
References (5) ← Not 12!

🏛️ CCM - Surviving Sepsis Campaign: International Guidelines for
         Management of Sepsis and Septic Shock 2021

📊 NEJM - Norepinephrine versus Dopamine for the Treatment of Septic
          Shock: A Systematic Review and Meta-Analysis

🔬 Lancet - Goal-Directed Resuscitation for Patients with Early
            Septic Shock (ARISE Trial)

📚 JAMA - Balanced Crystalloids versus Saline in Critically Ill Adults:
          Systematic Review

🔬 NEJM - Balanced Crystalloids versus Saline in Critically Ill Adults
          (SMART Trial)
```

#### Browser - Synthesis:

```
## Guideline-Recommended Initial Management

The Surviving Sepsis Campaign 2021 guidelines recommend early recognition
and treatment within 1 hour of identification {ref-1}. Obtain blood cultures
before antibiotic administration, but do not delay antibiotics beyond 45
minutes {ref-1}. Administer empiric broad-spectrum antibiotics with activity
against likely pathogens based on clinical syndrome {ref-2}.

Fluid resuscitation should begin immediately with crystalloid solutions
(normal saline or balanced crystalloids) {ref-1}. The guidelines recommend
an initial bolus of 30 mL/kg within the first 3 hours for patients with
sepsis-induced hypoperfusion {ref-1}. Balanced crystalloids may be preferred
over normal saline based on the SMART trial, which showed lower rates of
death or new renal-replacement therapy (14.3% vs 15.4%, OR 0.90, 95% CI
0.82-0.99, p=0.04) {ref-5}.

## Vasopressor Therapy and Hemodynamic Targets

Norepinephrine is the first-choice vasopressor, initiated at 0.05 mcg/kg/min
and titrated to maintain MAP ≥65 mmHg {ref-1}. Meta-analysis of 28 RCTs
(n=3,544 patients) showed norepinephrine associated with lower mortality
compared to dopamine (RR 0.89, 95% CI 0.81-0.98, p=0.02) {ref-2}. Vasopressin
(0.03-0.04 units/min) may be added as second-line therapy {ref-1}.
```

---

## 🏆 Success Criteria

You'll know it's working when:

### Visual Design:

✅ **4-6 reference badges** (not 10-15)
✅ **Less pink/blue clutter** (fewer ICM/CCM badges)
✅ **More orange/purple** (NEJM, Lancet, JAMA - top journals)
✅ **Cleaner page** (easier to scan)

### Content Quality:

✅ **Guidelines mentioned first** ("Surviving Sepsis Campaign recommends...")
✅ **Meta-analysis data** ("Meta-analysis of 28 RCTs showed...")
✅ **Major trial names** ("PLATO trial", "ARISE trial", "SMART trial")
✅ **Guideline-level certainty** (not "one study suggests" but "guidelines recommend")

### Evidence Structure:

✅ **Top reference is a guideline** (if available for topic)
✅ **Next 1-2 are meta-analyses** (pooled evidence)
✅ **Last 2-3 are landmark RCTs** (PLATO, ARISE, SMART, etc.)
✅ **Total ≤6 references** (clean, authoritative)

---

## 🎉 Impact

### Before: Generic Evidence Dump

- 12 random papers
- No clear hierarchy
- Hard to know what to trust
- Visual clutter (too many badges)
- Missing guideline recommendations

### After: OpenEvidence-Quality Synthesis

- 4-6 highest-quality sources
- Clear evidence hierarchy (Guidelines → Meta-analyses → RCTs)
- Easy to trust (starts with consensus recommendations)
- Clean design (fewer badges)
- **Matches how clinicians actually make decisions** ✅

---

**Test it now with "management of septic shock"!** 🚀

The synthesis should start with Surviving Sepsis Campaign guidelines, support with meta-analysis data, and show only 4-6 authoritative references total.
